Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-04-16
Original SEC Filing: Click here

---

Webplus: SVA/20190416/6-K/2_EX-99.1/000.htm SEC Original: tv518987_ex99-1.htm
Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectious Disease · The Sinovac-developed sIPV demonstrates both long-term affordability and accessibility and has the potential to contribute significantly to polio eradication in developing countries and the progress towards a polio-free world. April 16, 2019 08:00 AM Eastern Daylight

---

---

Webplus: SVA/20190416/6-K/1/000.htm SEC Original: tv518987_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-04-16CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200